Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.


The treatment paradigm for early stage lung cancer and oligometastatic disease to the lung is rapidly changing. Ablative therapies, especially stereotactic body radiation therapy, are challenging the surgical gold standard and have the potential to be the standard for operable patients with early stage lung cancer who are high risk due to co- morbidities… (More)
DOI: 10.1016/j.soc.2016.02.008